RNU6-1256P

Across TCGA pan-cancer cohorts, RNU6-1256P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RNU6-1256P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU6-1256P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNU6-1256P expression acts as an unfavorable survival marker, although some lineages such as OV and STAD show a favorable association.

OV, SKCM, and CHOL are the cancer types where RNU6-1256P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	II,III,IV	0.617	0.517	.008	54	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	36	view →
CHOL	OS	Tertile	All	0.019	0.800	<.001	36	view →
STAD	OS	Tertile	III,IV	0.640	0.285	.007	34	view →
UCEC	OS	Tertile	All	0.559	0.689	.007	30	view →
PAAD	OS	Tertile	All	0.274	0.620	.004	27	view →
THYM	DFS	Tertile	II,III,IV	0.145	0.873	<.001	18	view →
UCS	DFS	Tertile	All	0.184	0.528	.035	18	view →
UVM	OS	Tertile	All	0.292	0.674	.035	18	view →
LAML	DFS	Tertile	All	0.513	0.299	.017	18	view →
KIRP	DFS	Tertile	III,IV	0.165	0.614	.005	18	view →
HNSC	OS	Tertile	IV	0.842	0.382	.024	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RNU6-1256P–OV (DFS)

Open the OV breakdown →